22 June 2022
According to Sergey Glagolev, Deputy Head of the Ministry of Health of the Russian Federation, the pharmaceutical market in Russia is growing steadily, with two–thirds of medicines being domestic drugs. He stated this during the International Research to Practice Conference “Assessment of healthcare technologies: improving the strategy for the development of the drug supply system”.
“The market is growing steadily. Its capitalization is about 2 trillion rubles. In physical terms, domestic medicines account for two–thirds of this volume,” RIA Novosti quotes Glagolev as saying.
As he noted, Russia provides full production cycle for 95% of domestic drugs. In addition, the Deputy minister added that the public medicines procurement market has recently grown by about 30%.
The Ministry of Health previously announced the growth of the market of domestic medicines and medical products, as well as the possibility of producing in Russia about 80% of VED-listed medicines.
PrintOctober 10 – World Mental Health Day
10 October 2024
Long-Term Game: NovaMedica Experts at the Pharma Marketing Conference
10 October 2024
NovaMedica in the TOP-1000 Russian Managers Rating
28 September 2024
The Ministry of Health approved a new indication for a non-small cell lung cancer drug
07 November 2024
Special rules for medicines and medical devices may extend to 2028
07 November 2024
Murashko discussed the progress of Russian innovative drugs
06 November 2024
The volume of production of dietary supplements increased by 27% in 2024 in Moscow
06 November 2024